Ortho Tri-Cyclen®

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Chronic Hepatitis CHepatitis C Virus

Phase 1

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

CompletedNCT00983957

Bristol-Myers SquibbChronic Hepatitis C

Start: 2009-10-31End: 2010-02-28Updated: 2015-10-16

Drug Interaction Oral Contraceptive Pill (OCP)

CompletedNCT01063023

Bristol-Myers SquibbHepatitis C Virus

Start: 2010-01-31End: 2010-06-30Updated: 2011-01-25